iRhythm’s CEO on Finding the Footing Needed to Deliver Disruptive Tech; ZB’s Tornos on Being Bold

In this episode of the DeviceTalks Weekly podcast, iRhythm CEO Quentin Blackford shares his MedTech journey, the tech powering iRhythm’s arrhythmia detection, and what it takes to disrupt traditional healthcare. He talks patient engagement, predictive care, and the company’s push deeper into primary care. In this week’s FOMO, you’ll hear my interview with Zimmer Biomet CEO and President Ivan Tornos. We kick things off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers, covering Medtronic, Alcon, Staar Surgical, Inspire Medical, Edwards Lifesciences, and HistoSonics. Thanks for tuning in to DeviceTalks Weekly. *** Enjoy this episode? Follow DeviceTalks Weekly on your favorite podcast app and on YouTube.com/@DeviceTalks. Want full access to the DeviceTalks Podcast Network? Subscribe at https://devicetalks.castos.com/subscribe Chapters (00:02:04) - Newmarkers Newsmakers(00:06:10) - Medtronic(00:09:43) - Alcon(00:13:43) - Inspire Medical Systems(00:16:52) - Edwards Lifesciences(00:19:05) - HistoSonics(00:26:23) - FOMO Interview, Ivan Tornos, CEO & President, Zimmer Biomet(00:34:15) - Keynote Interview, Quentin Blackford, CEO, iRhythm(00:39:23) - Moving from CFO to CEO(00:42:43) - iRhythm overview(00:45:35) - What does profitability mean for a MedTech?(00:47:05) - Why does change take so long in healthcare?(00:51:00) - How do you engage with patients?(00:59:34) - Partnership with Lucem for predictive diagnostics(01:02:13) - Impact of Epic collaboration(01:06:57) - Importance of primary care physicians

There are no comments yet.

Please log in to write the first comment.